BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36067062)

  • 1. Adverse events after SARS-CoV-2 vaccination in solid organ transplant recipients: A systematic review.
    Villavicencio A; Ebisu Y; Raja M; Sanchez-Covarrubias AP; Reynolds JM; Natori Y
    Transpl Infect Dis; 2022 Dec; 24(6):e13936. PubMed ID: 36067062
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
    Karaba AH; Zhou W; Li S; Aytenfisu TY; Johnston TS; Akinde O; Eby Y; Abedon AT; Alejo JL; Qin CX; Thompson EA; Garonzik-Wang JM; Blankson JN; Cox AL; Bailey JR; Klein SL; Pekosz A; Segev DL; Tobian AAR; Werbel WA
    Clin Infect Dis; 2023 Feb; 76(3):e495-e498. PubMed ID: 35959783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.
    Qin CX; Auerbach SR; Charnaya O; Danziger-Isakov LA; Ebel NH; Feldman AG; Hsu EK; McAteer J; Mohammad S; Perito ER; Thomas AM; Chiang TPY; Garonzik-Wang JM; Segev DL; Mogul DB
    Am J Transplant; 2022 Oct; 22(10):2481-2483. PubMed ID: 35510786
    [No Abstract]   [Full Text] [Related]  

  • 4. Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.
    Subramanian V
    J Infect Dis; 2023 Aug; 228(Suppl 1):S34-S45. PubMed ID: 37539762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case Series.
    Chang A; Alejo JL; Abedon AT; Mitchell J; Chiang TP; Boyarsky BJ; Avery RK; Tobian AAR; Levan ML; Warren DS; Massie AB; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 Feb; 106(2):e161-e162. PubMed ID: 34789691
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update.
    Mitchell J; Alejo JL; Chiang TPY; Kim J; Chang A; Abedon AT; Avery RK; Tobian AAR; Massie AB; Levan ML; Warren DS; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 Jul; 106(7):e338-e340. PubMed ID: 35426888
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of Acquisition of COVID-2019 Neutralizing Antibodies in Organ Transplant Recipients.
    Akimoto S; Onoe T; Morimoto H; Yamaguchi S; Shibata Y; Tazuma S; Sada H; Shimada N; Tazawa H; Suzuki T; Sudo T; Shimizu Y; Tashiro H
    Transplant Proc; 2023 May; 55(4):815-819. PubMed ID: 37147198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Antibody Response After a Fifth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Abedon AT; Teles MS; Alejo JL; Kim JD; Mitchell J; Chiang TPY; Avery RK; Tobian AAR; Levan ML; Warren DS; Massie AB; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 May; 106(5):e262-e263. PubMed ID: 35175241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month Antibody Kinetics and Durability After 3 Doses of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Abedon AT; Alejo JL; Kim JD; Thomas L; Mitchell J; Chiang TPY; Avery RK; Tobian AAR; Levan ML; Warren DS; Massie AB; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 May; 106(5):e281-e283. PubMed ID: 35066543
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination.
    Wadei HM; Gonwa TA; Leoni JC; Shah SZ; Aslam N; Speicher LL
    Am J Transplant; 2021 Oct; 21(10):3496-3499. PubMed ID: 33890410
    [No Abstract]   [Full Text] [Related]  

  • 11. A Review of Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination Following Solid Organ Transplantation.
    Cieślak I; Kwapisz M; Tronina O; Gotlib J; Lisik W; Wasiak D; Hreńczuk M; Rahnama M; Małkowski P
    Ann Transplant; 2022 Sep; 27():e936949. PubMed ID: 36110033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS-CoV-2 vaccines in solid organ transplant recipients: A case series.
    Chang A; Mitchell J; Alejo JL; Chiang TPY; Abedon AT; Kim JD; Avery RK; Tobian AAR; Levan ML; Warren DS; Garonzik-Wang JM; Massie AB; Segev DL; Werbel WA
    Clin Transplant; 2022 Sep; 36(9):e14772. PubMed ID: 35822545
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective study.
    Ajlan AA; Ali T; Aleid H; Almeshari K; DeVol E; Alkaff MA; Fajji L; Alali A; Halabi D; Althuwaidi S; Alghamdi S; Ullah A; Alrajhi A; Bzeizi K; Almaghrabi R; Marquez KAH; Elmikkaoui B; Albogumi E; Aldakhil H; Al-Awwami M; Broering DC
    BMC Infect Dis; 2022 Oct; 22(1):786. PubMed ID: 36229772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-month antibody kinetics and durability after four doses of a SARS-CoV-2 vaccine in solid organ transplant recipients.
    Mitchell J; Chiang TP; Alejo JL; Kim JD; Chang A; Abedon AT; Avery RK; Tobian AAR; Levan ML; Warren DS; Garonzik-Wang JM; Segev DL; Massie AB; Werbel WA
    Clin Transplant; 2023 Jan; 37(1):e14868. PubMed ID: 36437691
    [No Abstract]   [Full Text] [Related]  

  • 15. Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis.
    Ravanan R; Mumford L; Ushiro-Lumb I; Callaghan C; Pettigrew G; Thorburn D; Gardiner D; Forsythe J;
    Transplantation; 2021 Nov; 105(11):e263-e264. PubMed ID: 34310530
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.
    Svorcova M; Novysedlak R; Lischke R; Vachtenheim J; Strizova Z
    Front Immunol; 2022; 13():906225. PubMed ID: 35720376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccination in our transplant recipients: The time is now.
    Aslam S; Goldstein DR; Vos R; Gelman AE; Kittleson MM; Wolfe C; Danziger-Isakov L
    J Heart Lung Transplant; 2021 Mar; 40(3):169-171. PubMed ID: 33487534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: Erratum.
    Transplantation; 2024 May; 108(5):e77. PubMed ID: 38659118
    [No Abstract]   [Full Text] [Related]  

  • 19. Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.
    Cao J; Liu X; Muthukumar A; Gagan J; Jones P; Zu Y
    Clin Chem; 2021 Dec; 68(1):251-253. PubMed ID: 34358295
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients.
    Boyarsky BJ; Chiang TP; Teles AT; Greenberg RS; Krach MR; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL; Werbel AWA
    Transplantation; 2021 Oct; 105(10):e137-e138. PubMed ID: 34241987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.